Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Videlis Nduba

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Medrxiv : the Preprint Server for Health Sciences|April 10, 2026
Evaluation of non-sputum-based diagnostics for pediatric tuberculosis: the Pediatric TB Diagnostic (PDTBDx) cohort protocolBrendan Mullen, Joy Githua, Jaclyn N Escudero, et al.
Vaccine|May 12, 2026
Design and feasibility considerations for a phase 3 efficacy trial of the M72/AS01<sub>E-4</sub> tuberculosis vaccineAlemnew F Dagnew, Robert Noble, Amy Cinar, et al.
The Lancet. Haematology|April 10, 2021
Voxelotor in adolescents and adults with sickle cell disease (HOPE): long-term follow-up results of an international, randomised, double-blind, placebo-controlled, phase 3 trialJo Howard, Kenneth I Ataga, Robert C Brown, et al.
Open Forum Infectious Diseases|February 9, 2026
C-Reactive Protein for Pulmonary Tuberculosis Screening and Treatment Response Monitoring in ChildrenJoy Githua, Jerphason Mecha, Joshua Stern, et al.
Pediatric Blood & Cancer|February 25, 2021
Pharmacokinetics and safety of ticagrelor in infants and toddlers with sickle cell disease aged <24 monthsBaba Psalm Duniva Inusa, Adlette Inati, Philip Maes, et al.
Open Forum Infectious Diseases|March 6, 2025
Pulmonary Tuberculosis Infectiousness of Persons Identified Through Active and Passive Case-finding in a High-burden SettingLilian N Njagi, Khai Hoan Tram, Jerry S Zifodya, et al.
PLOS Global Public Health|February 18, 2025
Persistently high TB prevalence in Nairobi County neighbourhoods, 2015-2022Jane R Ong'ang'o, Jennifer Ross, Richard Kiplimo, et al.
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
Clinical and transcriptomic risk factors for post-tuberculosis lung disease in a cohort of Kenyan adultsJerry S Zifodya, Lucy A Kijaro, Videlis Nduba, et al.
Medrxiv : the Preprint Server for Health Sciences|April 29, 2026
A whole-blood transcriptional signature associated with obstructive post-tuberculosis lung diseaseRenee E Newby, Lucy Kijaro, Kimberly A Dill-McFarland, et al.
Blood|July 18, 2022
Ticagrelor vs placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: the HESTIA3 studyMatthew M Heeney, Miguel R Abboud, Jessie Githanga, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Medrxiv : the Preprint Server for Health Sciences|April 10, 2026
Evaluation of non-sputum-based diagnostics for pediatric tuberculosis: the Pediatric TB Diagnostic (PDTBDx) cohort protocolBrendan Mullen, Joy Githua, Jaclyn N Escudero, et al.
Vaccine|May 12, 2026
Design and feasibility considerations for a phase 3 efficacy trial of the M72/AS01<sub>E-4</sub> tuberculosis vaccineAlemnew F Dagnew, Robert Noble, Amy Cinar, et al.
The Lancet. Haematology|April 10, 2021
Voxelotor in adolescents and adults with sickle cell disease (HOPE): long-term follow-up results of an international, randomised, double-blind, placebo-controlled, phase 3 trialJo Howard, Kenneth I Ataga, Robert C Brown, et al.
Open Forum Infectious Diseases|February 9, 2026
C-Reactive Protein for Pulmonary Tuberculosis Screening and Treatment Response Monitoring in ChildrenJoy Githua, Jerphason Mecha, Joshua Stern, et al.
Pediatric Blood & Cancer|February 25, 2021
Pharmacokinetics and safety of ticagrelor in infants and toddlers with sickle cell disease aged <24 monthsBaba Psalm Duniva Inusa, Adlette Inati, Philip Maes, et al.
Open Forum Infectious Diseases|March 6, 2025
Pulmonary Tuberculosis Infectiousness of Persons Identified Through Active and Passive Case-finding in a High-burden SettingLilian N Njagi, Khai Hoan Tram, Jerry S Zifodya, et al.
PLOS Global Public Health|February 18, 2025
Persistently high TB prevalence in Nairobi County neighbourhoods, 2015-2022Jane R Ong'ang'o, Jennifer Ross, Richard Kiplimo, et al.
American Journal of Respiratory and Critical Care Medicine|February 25, 2026
Clinical and transcriptomic risk factors for post-tuberculosis lung disease in a cohort of Kenyan adultsJerry S Zifodya, Lucy A Kijaro, Videlis Nduba, et al.
Medrxiv : the Preprint Server for Health Sciences|April 29, 2026
A whole-blood transcriptional signature associated with obstructive post-tuberculosis lung diseaseRenee E Newby, Lucy Kijaro, Kimberly A Dill-McFarland, et al.
Blood|July 18, 2022
Ticagrelor vs placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: the HESTIA3 studyMatthew M Heeney, Miguel R Abboud, Jessie Githanga, et al.
Pageof 4